Last reviewed · How we verify
Support of pincer nail correction — Treatment Landscape & Competitive Intelligence
3 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Acetadote | Acetylcysteine | Bristol-Myers Squibb | Antidote | Glutathione levels; reactive metabolite of acetaminophen | 1963-01-01 | |
| Acetadote | Acetadote | University of Texas Southwestern Medical Center | Cystine/glutamate transporter, Cytochrome c, Glutathione synthetase | |||
| Acetylcystein | Acetylcystein | University Hospital, Strasbourg, France | Cystine/glutamate transporter, Cytochrome c, Glutathione synthetase |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Bristol-Myers Squibb · 1 drug in Support of pincer nail correction
- University Hospital, Strasbourg, France · 1 drug in Support of pincer nail correction
- University of Texas Southwestern Medical Center · 1 drug in Support of pincer nail correction
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Support of pincer nail correction:
- Support of pincer nail correction treatment updates — RSS
- Support of pincer nail correction treatment updates — Atom
- Support of pincer nail correction treatment updates — JSON
Cite this brief
Drug Landscape (2026). Support of pincer nail correction — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/support-of-pincer-nail-correction. Accessed 2026-06-10.
Related
- Support of pincer nail correction full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing